Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
2009420 citationsArnaud Scherpereel, Thierry Berghmans et al.European Respiratory Journalprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Thierry Berghmans
Since
Specialization
Citations
This map shows the geographic impact of Thierry Berghmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Berghmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Berghmans more than expected).
Fields of papers citing papers by Thierry Berghmans
This network shows the impact of papers produced by Thierry Berghmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Berghmans. The network helps show where Thierry Berghmans may publish in the future.
Co-authorship network of co-authors of Thierry Berghmans
This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Berghmans.
A scholar is included among the top collaborators of Thierry Berghmans based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Thierry Berghmans. Thierry Berghmans is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Berghmans, Thierry, Antoine Cortot, Bogdan Grigoriu, et al.. (2014). Les recommandations de pratique clinique de l'European Lung Cancer Working Party: Mises à jour.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 35(3). 132–133.1 indexed citations
Sculier, Jean‐Paul, Thierry Berghmans, & Anne‐Pascale Meert. (2010). Update in Lung Cancer and Mesothelioma 2009. American Journal of Respiratory and Critical Care Medicine. 181(8). 773–781.10 indexed citations
9.
Berghmans, Thierry, M. Dusart, Marianne Paesmans, et al.. (2008). El valor de captacion estandarizado (SUVmax) del tumor primario medido con tomografia de emission de postrones con fluorodesoxiglucosa (FDG-PET) tiene valor pronostico para la supervivencia en el cancer de pulmon no microcitico (CPNMC): Una revision sistematica y metaanalisis (MA) del European Lung Cancer Working Party para el IASLC Lung Cancer Staging Project. Journal of Thoracic Oncology. 2. 53–60.1 indexed citations
10.
Berghmans, Thierry & Vincent Ninane. (2008). Les infections pulmonaires. Revue des Maladies Respiratoires. 19. 56–62.
Paesmans, Marianne, Thierry Berghmans, Céline Mascaux, et al.. (2006). Prognostic role of thyroid transcription factor (TTF-1) in lung cancer: a meta-analysis of the published studies. Lung Cancer.
14.
Delmotte, P., Benoı̂t Martin, Marianne Paesmans, et al.. (2002). VEGF et survie des patients atteints d'un cancer pulmonaire. Revue systématique avec méta-analyse.. Revue des Maladies Respiratoires. 19(5). 577–584.53 indexed citations
15.
Berghmans, Thierry, Anne‐Pascale Meert, Céline Mascaux, et al.. (2002). Citation factors are not reflecting the methodological quality of lung cancer randomised trials.. Annals of Oncology. 13. 134.3 indexed citations
Sculier, Jean‐Paul, Marianne Paesmans, Jean‐Jacques Lafitte, et al.. (1999). Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy. Clinical & Translational Oncology. 1(2). 92–100.2 indexed citations
18.
Meert, Anne‐Pascale, Thierry Berghmans, Fabrice Branle, et al.. (1999). Phase II and III studies with new drugs for non small cell lung carcinoma: a systematic review of the literature with a methodology quality assessment. Lung Cancer.1 indexed citations
19.
Luce, Sylvie, Marianne Paesmans, Thierry Berghmans, et al.. (1998). [Critical review of the randomized trials assessing the role of adjuvant thoracic irradiation and chemotherapy in the treatment of limited-stage small cell lung cancer].. PubMed. 15(5). 633–41.15 indexed citations
20.
Berghmans, Thierry, Jean‐Paul Sculier, Dominique de Valeriola, & Jean Klášterský. (1994). Phase I study of Amphotericin B lipid complex with ABLC pharmacokinetics in patients receiving antineoplastic therapy. Annals of Oncology. 5. 202.12 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.